Click Therapeutics Acquires Assets of Better Therapeutics, Inc.

May 22, 2024

Click Therapeutics has acquired the assets of Better Therapeutics, Inc., including the FDA-authorized digital therapeutic AspyreRx (BT-001) and development candidates BT-002, BT-003 and BT-004. Click will integrate Better’s intellectual property into its AI-enabled platform to accelerate development of obesity and cardiometabolic digital therapeutics, optimizing programs for use alongside anti-obesity and diabetes medications.

Buyers
Click Therapeutics, Inc.
Targets
Better Therapeutics, Inc.
Sellers
Better Therapeutics, Inc.
Industry
Medical Devices
Location
California, United States
Transaction Type
Divestiture

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.